NASDAQ | VICL: 1.09  -0.01

By synergizing vaccine and DNA technologies, Vical is creating new therapies, and shaping the future of vaccines. Our vision is to realize the promise of novel preventive and therapeutic alternatives for serious and life-threatening diseases.

Vical's core technology grew out of a chance discovery and provided the cornerstones for two new biopharmaceutical industry sectors: DNA vaccines and non-viral gene therapy. 

Vical's management systematically leveraged that technology into a broad portfolio of independent and partnered product development programs. The first products for animal health are on the market. The first human products are approaching.

PRODUCT PIPELINE

P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121
Designed by Mentus
This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.